Free Trial

Aesther Healthcare Acquisition (AEHAW) Competitors

$0.0098 +0.00 (+84.91%)
As of 08/1/2025

AEHAW vs. ATNFW, LBPSW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying Aesther Healthcare Acquisition stock or one of its competitors? The main competitors of Aesther Healthcare Acquisition include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Aesther Healthcare Acquisition vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Aesther Healthcare Acquisition (NASDAQ:AEHAW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Aesther Healthcare AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Aesther Healthcare Acquisition N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Aesther Healthcare Acquisition. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Aesther Healthcare Acquisition. 180 Life Sciences' average media sentiment score of 0.95 beat Aesther Healthcare Acquisition's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
Aesther Healthcare Acquisition Neutral

Summary

180 Life Sciences beats Aesther Healthcare Acquisition on 2 of the 2 factors compared between the two stocks.

Get Aesther Healthcare Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for AEHAW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEHAW vs. The Competition

MetricAesther Healthcare AcquisitionPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$784.96M$2.56B$9.53B
Dividend YieldN/A4.84%2.61%4.14%
P/E RatioN/A1.3022.2223.88
Price / SalesN/A25.0584.9698.82
Price / CashN/A19.5627.0858.35
Price / BookN/A6.4739.575.60
Net IncomeN/A-$4.35M$28.61M$265.26M
7 Day PerformanceN/A-4.23%-0.55%-0.14%
1 Month PerformanceN/A-0.82%-0.09%6.08%
1 Year PerformanceN/A18.41%31.58%24.22%

Aesther Healthcare Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+84.9%
N/A-74.2%$0.00N/A0.002
ATNFW
180 Life Sciences
N/A$0.01
+6.1%
N/A+38.2%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AIMDW
Ainos
N/A$0.12
flat
N/A+57.3%$0.00$106.21K0.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-41.2%$0.00$585.60M0.004Positive News
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
-0.6%
N/A-24.8%$0.00N/A0.0015High Trading Volume
BFRIW
Biofrontera
N/A$0.15
-16.7%
N/A+214.7%$0.00$38.00M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.01
-32.2%
N/A-99.0%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.04
-10.0%
N/A-79.9%$0.00N/A0.008Positive News
Short Interest ↑
Gap Up
CALA
Calithera Biosciences
2.0876 of 5 stars
N/AN/A-98.4%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:AEHAW) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners